Vijay Kirpalani's Biography

Vijay Kirpalani, Founder President, Flow Chemistry Society - India Chapter, India

Mr. Vijay Kirpalani, Founder President, Flow Chemistry Society – India Chapter has obtained his B.E. (Chemical Engg.) from Maharaja Sayajirao University, Baroda. He is also a CEO, Pi-Process Intensification Experts LLP; Director of Sharon Bio-Medicine Ltd. As well as ChemSphere Consultants P. Ltd.; Partner, ChemSphere Technologies and Director, Mehta API (P) Ltd.
He is expert in Process Intensification, Flow Chemistry, Bio-catalysis, Process Design & Execution (of cGMP HAPI / API / Pharma Formulation, Chemical, Fine-Chemical, Biotech & Nanotech Facilities), QbD, PAT, Reg Affairs. He has Experience with an extensive repertoire of process technologies that have been developed and commercialized across over 100 grass-roots plants with > 200 processes in 14 countries.
In 2012, he conceived the scheme and led the Team as Director & Head – receiving a Grant of Rs. 6.9o Cr from DSIR (under the Technology-Development&Demo Programme) for development of Enzymes and Chemo-enzymatic methods to Chiral APIs & Intermediates including setting-up of a state-of-the-art biotech laboratory.
He had also Worked with BARC (Bhabha Atomic Research Center), Bharat Petroleum, IPCL, United Phosphorous Ltd., Baroda Productivity Council, etc.

other conference

Continuous Manufacturing in Biosimilars and Biologics
18 Jul, 2025

Continuous Manufacturing in Biosimilars and Biologics

Details
AI, and ML in Pharmaceutical R&D and Manufacturing Workflows
22 Aug, 2025

AI, and ML in Pharmaceutical R&D and Manufacturing Workflows

Details
Mastering Flow Chemistry: Scalable Solutions for API and Chemicals
17 Sep, 2025

Mastering Flow Chemistry: Scalable Solutions for API and Chemicals

Details
Flow Chemistry India 2025
18 - 19 Sep, 2025

Flow Chemistry India 2025

Ahmedabad

Details
Navigating Complexities in Pharmaceutical Analysis, Quality & Regulatory Compliance
06 - 07 Nov, 2025

Navigating Complexities in Pharmaceutical Analysis, Quality & Regulatory Compliance

Details
Advances in CRISPR-Cas Genome Editing in Plants
10 - 12 Dec, 2025

Advances in CRISPR-Cas Genome Editing in Plants

Details
whatsapp button